Kelly Grant
Health reporter at The Globe and Mail who provides analysis on drug labeling, public and private drug coverage, and clinical implications for access to GLP-1 medications.
Best podcasts with Kelly Grant
Ranked by the Snipd community
26 snips
Feb 23, 2026 • 31min
Skinny, Inc. Part 1: the Canadian connection to Ozempic
Kelly Grant, veteran health reporter, breaks down rising obesity trends and patient stories around GLP-1 drugs. Dr. Daniel Drucker, pioneering endocrinologist, walks through decades of research from a Gila monster discovery to semaglutide’s development. They discuss how these medicines work, broader health effects beyond weight, treatment challenges, and why the drugs captured public attention.
Mar 2, 2026 • 33min
Skinny, Inc. Part 2: The big business of Ozempic
Kelly Grant, a Globe health reporter who covers drug coverage and clinical access, and Chris Hannay, a Globe business-of-health reporter who explains pharma economics and patents. They discuss why semaglutide (Ozempic/Wegovy) exploded in use. They cover generics arriving in Canada, expected price drops, how coverage differs across public and private plans, and how virtual pharmacies screen for prescriptions.
